Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (511-520 of 561) with videos related to

Pageof 57
Sort By:
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Minerva Urology and Nephrology|June 26, 2024
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costsFrancesco Del Giudice, Anas Tresh, Shufeng Li, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
World Journal of Urology|November 24, 2020
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomesWojciech Krajewski, Marco Moschini, Joanna Chorbińska, et al.
Urologic Oncology|September 28, 2021
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohortSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
Cancers|October 14, 2023
Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair AnalysisEtienne Courboin, Romain Mathieu, Valentina Panetta, et al.
Journal of Endourology|February 3, 2022
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication IndexSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Pageof 57

Showing results (511-520 of 561) with videos related to

Sort By:
Pageof 57
Minerva Urology and Nephrology|February 20, 2023
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registryJulien Sarkis, Romain Diamand, Fouad Aoun, et al.
Minerva Urology and Nephrology|June 26, 2024
The impact of venous thromboembolism before open or minimally-invasive radical cystectomy in the USA: insurance claims data on perioperative outcomes and healthcare costsFrancesco Del Giudice, Anas Tresh, Shufeng Li, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
BJU International|March 13, 2026
Risk stratification and conditional recurrence after radical cystectomy: toward adaptive follow-upRoberto Contieri, Alberto Martini, Marc Furrer, et al.
World Journal of Urology|November 24, 2020
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomesWojciech Krajewski, Marco Moschini, Joanna Chorbińska, et al.
Urologic Oncology|September 28, 2021
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohortSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
The Journal of Urology|September 22, 2021
An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate CancerAlberto Martini, Timo F W Soeterik, Hester Haverdings, et al.
European Urology Oncology|January 29, 2025
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder CancerChris Ho-Ming Wong, Ivan Ching-Ho Ko, David Ka-Wai Leung, et al.
Cancers|October 14, 2023
Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair AnalysisEtienne Courboin, Romain Mathieu, Valentina Panetta, et al.
Journal of Endourology|February 3, 2022
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication IndexSimone Albisinni, Romain Diamand, Georges Mjaess, et al.
Pageof 57